Edition:
United Kingdom

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Global Market

0.16USD
15 Dec 2017
Change (% chg)

$0.01 (+5.27%)
Prev Close
$0.15
Open
$0.15
Day's High
$0.16
Day's Low
$0.15
Volume
621,484
Avg. Vol
898,470
52-wk High
$5.65
52-wk Low
$0.13

Select another date:

Tue, Nov 28 2017

BRIEF-Argos Therapeutics Enters Into Agreement With Saint-Gobain Performance Plastics Corp

* ARGOS THERAPEUTICS - ‍ON NOV 22, ENTERED INTO A SATISFACTION AND RELEASE AGREEMENT WITH SAINT-GOBAIN PERFORMANCE PLASTICS CORP - SEC FILING

BRIEF-Argos Provides Financial Update

* ARGOS THERAPEUTICS - ‍TKC PROPERTIES HAS, WITH ARGOS' FULL CONSENT, SUCCESSFULLY COMPLETED SALE OF FACILITY IN DURHAM COUNTY, NC TO A THIRD PARTY​

BRIEF-Argos reports third quarter financial results

* Argos reports third quarter 2017 financial results and operational highlights

BRIEF-Argos Therapeutics files for offering of 13.5 mln shares of common stock by Invetech

* Argos Therapeutics files for offering of 13.5 million shares of common stock by Invetech Pty Ltd - SEC filing Source text: (http://bit.ly/2zcHDkV) Further company coverage:

BRIEF-Argos Therapeutics enters into agreement with Invetech

* Argos Therapeutics - On September 22, 2017 co entered into a satisfaction and release agreement with Invetech PTY Ltd ‍​ - SEC filing

BRIEF-‍Argos doses first HIV patient with AGS-004

* ‍Argos announces first dosing of HIV patient with AGS-004 derived from latent viral reservoir​

BRIEF-Argos Therapeutics files for possible resale up to 18.9 mln shares

* Argos Therapeutics Inc files for possible resale up to 18.9 million shares of common stock of argos therapeutics, inc. By pharmstandard international s.a Source text: (http://bit.ly/2uQ9e6l) Further company coverage:

BRIEF-Argos Therapeutics Q2 loss per share $ 0.21

* Argos Therapeutics reports second quarter 2017 financial results and recent operational highlights

Select another date: